It may be a useful prompt for medication review, as it is associated with problems of medication management and suboptimal prescribing. However, polypharmacy is not a clinically useful independent marker of the quality use of medicines. The type and dose of medications rather than the number of medications determine meaningful clinical outcomes. 1 The more drugs a patient takes, the harder it may be to obtain an accurate medication history, which impedes informed medication review and prescribing. The incidence of adverse drug reactions increases with the number of medications used. Polypharmacy is a barrier to adherence because of the associated complex medication regimens, increased risk of adverse drug events and high medication costs. Poor adherence contributes to the increased risk of medication errors seen with polypharmacy.
Polypharmacy is associated with suboptimal prescribing. The more drugs a patient is exposed to, the more likely they are to be prescribed inappropriately. 2 'Potentially inappropriate medications' in the elderly include those with sedative or anticholinergic effects and long-acting non-steroidal antiinflammatory drugs. 3 Polypharmacy may occur when additional drugs are prescribed to treat the adverse effects of other drugs. This is known as the 'prescribing cascade'. 4 Other suboptimal prescribing associated with polypharmacy includes prescription of more than one drug in the same class or prescription of a drug that interacts with or is contraindicated in combination with another of the patient's medicines. Ironically, in a study of older patients the probability of under-prescribing -defined as lack of an indicated drug when no reason could be found for not prescribing it -also increased significantly with the number of drugs prescribed. 5 The risk of falls is increased with polypharmacy. This association is partly due to the chronic diseases for which the multiple medications are prescribed. 6 With polypharmacy, the increased use of specific classes of drugs, especially centrally acting and cardiovascular medications, is also likely to be a factor in increasing the risk of falls. 7 The key issue is whether each drug has been prescribed appropriately, both individually and in the context of the patient's total medication exposure, risk of drug interactions, comorbidities, physiology and quality of life. Some drugs, particularly those with anticholinergic and sedative effects, impair physical and cognitive function in older people. The more drugs with these effects that patients are exposed to, in number and in dose, the poorer the patients' overall function. A tool such as the drug burden index 1 , which measures the patient's total exposure to anticholinergic and sedative medications using the principles of dose-response, provides a better indication of the risks of suboptimal prescribing than simply counting drugs.
There are several conditions in which the combined use of several drugs may be beneficial, appropriate, and advocated through evidence-based guidelines. 8 When the findings of clinical trials are adopted into practice, they can result in some patients being prescribed multiple drugs. As polypharmacy is sometimes considered to be less than optimal prescribing, Sarah Hilmer explores the dilemma.
Another dilemma is whether chemotherapy causes cognitive impairment. Janette Vardy discusses the evidence.
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